US Patent Issued to Jiangsu Yahong Meditech on May 27 for "Combinational uses of nitroxoline and its analogues with chemotherapies and immunotherapies in the treatment of cancers" (American, Japanese, Chinese Inventors)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,310,960, issued on May 27, was assigned to Jiangsu Yahong Meditech Co. Ltd. (Taizhou Jiangsu, China).

"Combinational uses of nitroxoline and its analogues with chemotherapies and immunotherapies in the treatment of cancers" was invented by Ke Pan (Chadds Ford, Pa.), Peng Huang (Okayama, Japan) and Qiang Li (China Medical, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Novel combination therapies involving nitroxoline, its analogue or pharmaceutically acceptable salt thereof with at least one additional anti-cancer chemotherapy or immunotherapy agent are described. Related kits, pharmaceutical compositions and methods of production arlinee also des...